Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00073008

Public ClinicalTrials.gov record NCT00073008. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 10:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Multicenter Trial Comparing Two Schedules of GW572016 as First or Second Line Monotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer With Either Bronchioloalveolar Carcinoma or No Smoking History

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study was designed to evaluate and compare the efficacy of two dose schedules of an oral investigational drug for the treatment of advanced or metastatic non-small cell lung cancer.

Study identification

NCT ID
NCT00073008
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
131 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2003 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Feb 28, 2017

2003 – 2008

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
GSK Investigational Site Jasper Alabama 35501 —
GSK Investigational Site Greenbrae California 94904-2007 —
GSK Investigational Site La Jolla California 92037 —
GSK Investigational Site Long Beach California 90813 —
GSK Investigational Site Poway California 92064 —
GSK Investigational Site Rancho Mirage California 92270 —
GSK Investigational Site Washington D.C. District of Columbia 20007 —
GSK Investigational Site Gainsville Florida 32610 —
GSK Investigational Site Elk Grove Village Illinois 60007 —
GSK Investigational Site Houma Louisiana 70360 —
GSK Investigational Site Metairie Louisiana 70006 —
GSK Investigational Site Lebanon New Hampshire 03756 —
GSK Investigational Site New Brunswick New Jersey 08901 —
GSK Investigational Site Santa Fe New Mexico 87505 —
GSK Investigational Site Nyack New York 10960 —
GSK Investigational Site Chapel Hill North Carolina 27599-7600 —
GSK Investigational Site Durham North Carolina 27707 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Portland Oregon 97213 —
GSK Investigational Site Philadelphia Pennsylvania 19140 —
GSK Investigational Site Nashville Tennessee 37203 —
GSK Investigational Site Corpus Christi Texas 78412 —
GSK Investigational Site Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00073008, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2017 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00073008 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →